A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
Status:
Completed
Trial end date:
2021-04-05
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of CKD-314 (Nafabelltan)
compared to standard of care (SOC), with respect to clinical status assessed by a 7-point
ordinal scale in hospitalized adult patients diagnosed with COVID-19 pneumonia